2551 — Marusan-Ai Co Balance Sheet
0.000.00%
- ¥8bn
- ¥13bn
- ¥33bn
- 48
- 50
- 22
- 31
Annual balance sheet for Marusan-Ai Co, fiscal year end - September 20th, JPY millions except per share, conversion factor applied.
2020 September 20th | 2021 September 20th | 2022 September 20th | 2023 September 20th | 2024 September 20th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3,060 | 1,964 | 2,500 | 2,085 | 3,919 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5,135 | 5,247 | 4,595 | 6,876 | 6,993 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11,345 | 10,963 | 11,650 | 12,604 | 14,485 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12,808 | 13,247 | 13,922 | 11,180 | 10,602 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 25,855 | 25,964 | 27,198 | 25,646 | 26,911 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11,537 | 10,510 | 12,164 | 12,014 | 12,444 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 19,381 | 19,434 | 20,564 | 19,975 | 20,431 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 6,474 | 6,530 | 6,634 | 5,670 | 6,480 |
| Total Liabilities & Shareholders' Equity | 25,855 | 25,964 | 27,198 | 25,646 | 26,911 |
| Total Common Shares Outstanding |